Explore Business Standard
Mylan Laboratories
The Council of Scientific and Industrial Research (CSIR) and Mylan Laboratories Limited will collaborate to identify potential therapies for COVID-19, the country's premier research body said in a statement on Wednesday. A series of clinical trials will be conducted towards new and innovative solutions to manage the COVID-19 pandemic in India as part of this collaboration. The first of the clinical trials to be rolled out is a multiple-arm phase 3 study that will be conducted in adult patients with mild to moderate COVID-19 at risk of complications, it said. "The Council of Scientific & Industrial Research (CSIR), India's premier research organisation, and Mylan Laboratories Limited, the India-based subsidiary of leading global pharmaceutical company Mylan, today announced a partnership to address unmet patient needs amidst the evolving COVID-19 pandemic," according to the statement. "Under the partnership, CSIR's constituent laboratory Indian Institute of Chemical Technology ...